Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study)

Bijlsma, S., et al. (2006). Large-scale human metabolomics studies: A strategy for data (pre) processing and validation. Analytical Chemistry, 78, 567–574.

Bonafe, L., et al. (2000). Evaluation of urinary acylglycines by electrospray tandem mass spectrometry in mitochondrial energy metabolism defects and organic acidurias. Molecular Genetics and Metabolism, 311, 302–311.

Caramori, M. Luiza, Fioretto, P., & Mauer, M. (2006). Enhancing the predictive value of urinary albumin for diabetic nephropathy. Journal of the American Society of Nephrology, 17(2), 339–352.

Chalmers, R. A., et al. (1984). Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: Evidence for secondary insufficiency of l-carnitine. Pediatric Research, 18(12), 1325–1328.

Eigenvector Research. (2008). PLS toolbox. Available at www.eigenvector.com

Finne, P., et al. (2005). Incidence of end-stage renal disease in patients with type 1 diabetes. Journal of the American Medical Association, 294(14), 1782–1787.

Groop, P.-H., et al. (2009). The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Baseline, 58(7), 1651–1658.

Gross, J. L., et al. (2005). Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care, 28(1), 164–176.

Hastie, T., Tibshirani, R., & Friedman, J. (2008). The elements of statistical learning (2nd ed.). New York: Springer.

Jankevics, A., et al. (2009). Chemometrics and intelligent laboratory systems metabolomic studies of experimental diabetic urine samples by 1 H NMR spectroscopy and LC/MS method. Chemometrics and Intelligent Laboratory Systems, 97(1), 11–17.

Johnson, D. W. (2005). Contemporary clinical usage of LC/MS: Analysis of biologically important carboxylic acids. Clinical Biochemistry, 38, 351–361.

Kador, P. F. et al. (2002). Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs. Investigative Ophthalmology, 43, 1916–1921.

Kemperman, R. F. J., et al. (2007). Comparative urine analysis by liquid chromatography-mass spectrometry and multivariate statistics: Method development, evaluation, and application to proteinuria research articles. Journal of Proteome Research, 6, 194–206.

Kimmelstiell, P., & Wilson, C. (1936). Benign and malignant hypertension and nephrosclerosis. American Journal of Pathology, 12, 4548.

Knecht, K. J., et al. (1992). Detection of 3-deoxyfructose and 3-deoxyglucosone human urine and plasma: Evidence for intermediate stages of the maillard reaction in viva. Review Literature and Arts of the Americas, 294(1), 130–137.

Koek, M. M., et al. (2006). Microbial metabolomics with gas chromatography/mass spectrometry. Analytical Chemistry, 78(4), 1272–1281.

Lachin, J. M., Genuth, S., Cleary, P., Davis, M. D., et al. (2000). Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. New England Journal of Medicine, 342, 381–389.

Lawson, A. M., Chalmers, R. A., & Watts, R. W. E. (1976). Urinary organic acids in man. I. Normal patterns. Clinical Chemistry, 1287, 1283–1287.

Lou, G. L., Pinsky, C., & Sitar, D. S. (1994). Kynurenic acid distribution into brain and peripheral tissues of mice. Canadian Journal of Physiology and Pharmacology, 72(2), 161–167.

Mäkinen, V. P., et al. (2006). Diagnosing diabetic nephropathy by 1 H NMR metabonomics of serum. Magnetic Resonance Materials in Physics Biology and Medicine, 19, 281–296.

Mäkinen, V. P, Forsblom, C., et al. (2008). Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes. Diabetes, 57, 2480–2487.

Mäkinen, V. P., Soininen, P., et al. (2008). H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Molecular Systems Biology, 4(167), 1–12.

Mathworks. (2008). Matlab. Available at www.mathworks.com .

Miller, J. N., & Miller, J. C. (2005). Statistics and chemometrics for analytical chemistry (5th ed.). England: Pearson Education Limited.

Mrocheck, J. E., & Rainey, W. T. J. (1972). Identification and biochemical significance of substituted furans in human urine. Clinical Chemistry, 18(8), 821–828.

Pampel, F. C. (2000). Logistic regression a primer, thousand oaks: Sage university papers on quantitative applications in the social sciences. Thousand Oaks: Sage Publications.

Pawlak, D., et al. (2002). Tryptophan metabolism via the kynurenine pathway in experimental. Nephron, 90, 328–335.

Qiu, Y., et al. (2008). Multivariate classification analysis of metabolomic data for candidate biomarker discovery in type 2 diabetes mellitus. Metabolomics, 4(4), 337–346.

Rebouche, C. J., & Seim, H., (1998). Carnitine metabolism and its regulation in microorganisms and mammals. The Annual Review of Nutrition, 18, 39–61.

Saude, E. J., et al. (2007). Variation of metabolites in normal human urine. Metabolomics, 3(4), 439–451.

Soedamah-Muthu, S. S., et al. (2004). Risk factors for coronary heart disease in type 1 diabetic patients in Europe: The EURODIAB prospective complications study. Diabetes Care, 27(2), 530–537.

Sokolova, M., & Lapalme, G. (2009). A systematic analysis of performance measures for classification tasks. Information Processing and Management, 45(4), 427–437.

Thomas, M. C., & Atkins, R. C. (2006). Blood pressure lowering for the prevention and treatment of diabetic kidney disease. Drugs, 66(17), 2213–2234.

van der Kloet, F. M., et al. (2009). Analytical error reduction using single point calibration for accurate and precise metabolomic phenotyping research articles. Journal of Proteome Research, 8, 5132–5141.

Vernez, L. (2005). Analysis of carnitine and acylcarnitines in biological fluids and application to a clinical study. PhD Thesis, University of Basel, Basel.

Wagner, S., Deufel, T., & Guder, W. (1986). Carnitine metabolism in isolated rat kidney cortex tubules. Biological Chemistry Hoppe-Seyler, 367, 75–79.

Westerhuis, J. A., et al. (2008). Discriminant Q2 (DQ2) for improved discrimination in PLSDA models. Metabolomics, 4(4), 293–296.

Wikoff, W. R., et al. (2009). Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proceedings of the National Academy of Sciences of the United States of America, 106(10), 3698–3703.

Zhang, Z., & Chan, D. W. (2005). Cancer proteomics: In pursuit of “true” biomarker discovery. Biomarkers, 14, 2283–2286.

Zhang, J., et al. (2009). Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system. Analytica Chimica Acta, 650(14), 16–22.